Genomic assays guide adjuvant therapy in HR-positive, HER2-negative breast cancer, clarifying who benefits from chemo by age, nodal status, and risk score.
Victoria Rizk, MD
Victoria Rizk, MD, is a medical oncologist at Tampa General Hospital Cancer Center.
Articles by Victoria Rizk, MD
